Hantavirus strain confirmedBy Hasina KathradaThe outbreak has entered a more serious phase after authorities confirmed that two cases detected in SA involve the Andes variant
Nine lessons to make SA’s anti-HIV jab rollout work In less than a month, South Africa will start rolling out the most potent HIV prevention medication the world has seen. But that alone doesn’t guarantee that HIV-negative people who need this twice-a-year injection — called lenacapavir — will use it By Katherine GillIt’s burning down there: How shame is keeping SA girls from looking after their sexual healthShame, silence and incomplete sex ed are stopping South African girls from getting treated for sexually transmitted infections — even as rates remain stubbornly high By Zoe DubyPassenger dies in SA as rare virus linked to international cruise ship outbreakHealth officials are monitoring possible exposures in Gauteng after passengers linked to a deadly cruise ship outbreak passed through South Africa, with one patient in critical condition in Sandton By Hasina KathradaPartner ContentWalking the nation together: The men turning endurance into hopeBy Bongani Nicholas Ngomane More HIV funding cuts are coming for SA. This time it’s a slow fade, but with clear risksBy Ida JoosteThe Global Fund to Fight Aids, Tuberculosis and Malaria will start to cut its grant support to South Africa in just two years, with its final grant ending in eight years. Some experts are worried the government isn’t doing enough to plan for it Teen pregnancies are dramatically dropping. But researchers aren’t sure whyBy Tanya PampaloneNew research shows a steep decline in adolescent pregnancy rates across all nine provinces from 2021 to 2025, reversing course from previous years. It’s good news, even if it’s not clear why it’s happening Our anti-HIV jab will be rolled out in six weeks. But funding cuts hollowed out the system needed to deliver itBy Mia MalanThe uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the Trump administration’s funding cuts to the country, a new report has found. Researchers conducted in-depth interviews with doctors, nurses, peer counsellors, transgender and young people, sex workers, gay and bisexual men and government health workers with personal experience of the funding cuts in Cape Town and Johannesburg The spirits, the marabouts and the 11 psychiatrists in Burkina FasoBy Sean ChristieIn Burkina Faso, more than 70 languages are spoken, armed conflict continues to escalate and half the country’s psychiatrists have left. With few mental health services available, families and traditional healers absorb what the system cannot Here’s how to make drug addiction a health issue, not a criminal oneBy Tanya Pampalone, Anna-Maria van Niekerk, Jessica Pitchford and Mia MalanExperts say South Africa’s contradictory approach to drugs — treating addiction as both a disease and a crime — is fuelling a worsening crisis in places like Westbury, where illicit drugs plague the community Our LEN is here; Now for quality checks in IrelandBy Mia MalanSA’s first consignment of the twice-a-year anti-HIV injection, lenacapavir — 37 920 doses — arrived last week at OR Tambo Airport via two shipments from Dublin. The batches reached the country six weeks later than expected. The delay of the shipment meant the health department couldn’t start its roll-out on April 1, as it had originally planned, and had to postpone it to mid to late May Global wars and fuel shocks are putting pregnant women at greater risk of dying in childbirthBy Emily MacleanAs wars disrupt fuel supplies and health systems, more women are being forced to give birth without timely access to skilled care Can talks save South Africa’s NHI from a courtroom war?By Mia Malan and Anna-Maria van NiekerkHealth Minister Aaron Motsoaledi has met the South African Medical Association — one of the organisations taking him to court about the National Health Insurance Act — to talk about “things we have in common”. President Cyril Ramaphosa is planning to meet Business Unity South Africa again after an initial meeting in 2024, during which they discussed alternatives to the NHI How a boy born on World TB Day helped turn the tide on SA’s deadliest TBBy Sean ChristieNorbert Ndjeka was born on World TB Day. Decades later, he would reshape how South Africa treats the deadliest forms of the disease 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
It’s burning down there: How shame is keeping SA girls from looking after their sexual healthShame, silence and incomplete sex ed are stopping South African girls from getting treated for sexually transmitted infections — even as rates remain stubbornly high By Zoe DubyPassenger dies in SA as rare virus linked to international cruise ship outbreakHealth officials are monitoring possible exposures in Gauteng after passengers linked to a deadly cruise ship outbreak passed through South Africa, with one patient in critical condition in Sandton By Hasina KathradaPartner ContentWalking the nation together: The men turning endurance into hopeBy Bongani Nicholas Ngomane More HIV funding cuts are coming for SA. This time it’s a slow fade, but with clear risksBy Ida JoosteThe Global Fund to Fight Aids, Tuberculosis and Malaria will start to cut its grant support to South Africa in just two years, with its final grant ending in eight years. Some experts are worried the government isn’t doing enough to plan for it Teen pregnancies are dramatically dropping. But researchers aren’t sure whyBy Tanya PampaloneNew research shows a steep decline in adolescent pregnancy rates across all nine provinces from 2021 to 2025, reversing course from previous years. It’s good news, even if it’s not clear why it’s happening Our anti-HIV jab will be rolled out in six weeks. But funding cuts hollowed out the system needed to deliver itBy Mia MalanThe uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the Trump administration’s funding cuts to the country, a new report has found. Researchers conducted in-depth interviews with doctors, nurses, peer counsellors, transgender and young people, sex workers, gay and bisexual men and government health workers with personal experience of the funding cuts in Cape Town and Johannesburg The spirits, the marabouts and the 11 psychiatrists in Burkina FasoBy Sean ChristieIn Burkina Faso, more than 70 languages are spoken, armed conflict continues to escalate and half the country’s psychiatrists have left. With few mental health services available, families and traditional healers absorb what the system cannot Here’s how to make drug addiction a health issue, not a criminal oneBy Tanya Pampalone, Anna-Maria van Niekerk, Jessica Pitchford and Mia MalanExperts say South Africa’s contradictory approach to drugs — treating addiction as both a disease and a crime — is fuelling a worsening crisis in places like Westbury, where illicit drugs plague the community Our LEN is here; Now for quality checks in IrelandBy Mia MalanSA’s first consignment of the twice-a-year anti-HIV injection, lenacapavir — 37 920 doses — arrived last week at OR Tambo Airport via two shipments from Dublin. The batches reached the country six weeks later than expected. The delay of the shipment meant the health department couldn’t start its roll-out on April 1, as it had originally planned, and had to postpone it to mid to late May Global wars and fuel shocks are putting pregnant women at greater risk of dying in childbirthBy Emily MacleanAs wars disrupt fuel supplies and health systems, more women are being forced to give birth without timely access to skilled care Can talks save South Africa’s NHI from a courtroom war?By Mia Malan and Anna-Maria van NiekerkHealth Minister Aaron Motsoaledi has met the South African Medical Association — one of the organisations taking him to court about the National Health Insurance Act — to talk about “things we have in common”. President Cyril Ramaphosa is planning to meet Business Unity South Africa again after an initial meeting in 2024, during which they discussed alternatives to the NHI How a boy born on World TB Day helped turn the tide on SA’s deadliest TBBy Sean ChristieNorbert Ndjeka was born on World TB Day. Decades later, he would reshape how South Africa treats the deadliest forms of the disease 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
Passenger dies in SA as rare virus linked to international cruise ship outbreakHealth officials are monitoring possible exposures in Gauteng after passengers linked to a deadly cruise ship outbreak passed through South Africa, with one patient in critical condition in Sandton By Hasina KathradaPartner ContentWalking the nation together: The men turning endurance into hopeBy Bongani Nicholas Ngomane
Partner ContentWalking the nation together: The men turning endurance into hopeBy Bongani Nicholas Ngomane
More HIV funding cuts are coming for SA. This time it’s a slow fade, but with clear risksBy Ida JoosteThe Global Fund to Fight Aids, Tuberculosis and Malaria will start to cut its grant support to South Africa in just two years, with its final grant ending in eight years. Some experts are worried the government isn’t doing enough to plan for it Teen pregnancies are dramatically dropping. But researchers aren’t sure whyBy Tanya PampaloneNew research shows a steep decline in adolescent pregnancy rates across all nine provinces from 2021 to 2025, reversing course from previous years. It’s good news, even if it’s not clear why it’s happening Our anti-HIV jab will be rolled out in six weeks. But funding cuts hollowed out the system needed to deliver itBy Mia MalanThe uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the Trump administration’s funding cuts to the country, a new report has found. Researchers conducted in-depth interviews with doctors, nurses, peer counsellors, transgender and young people, sex workers, gay and bisexual men and government health workers with personal experience of the funding cuts in Cape Town and Johannesburg The spirits, the marabouts and the 11 psychiatrists in Burkina FasoBy Sean ChristieIn Burkina Faso, more than 70 languages are spoken, armed conflict continues to escalate and half the country’s psychiatrists have left. With few mental health services available, families and traditional healers absorb what the system cannot Here’s how to make drug addiction a health issue, not a criminal oneBy Tanya Pampalone, Anna-Maria van Niekerk, Jessica Pitchford and Mia MalanExperts say South Africa’s contradictory approach to drugs — treating addiction as both a disease and a crime — is fuelling a worsening crisis in places like Westbury, where illicit drugs plague the community Our LEN is here; Now for quality checks in IrelandBy Mia MalanSA’s first consignment of the twice-a-year anti-HIV injection, lenacapavir — 37 920 doses — arrived last week at OR Tambo Airport via two shipments from Dublin. The batches reached the country six weeks later than expected. The delay of the shipment meant the health department couldn’t start its roll-out on April 1, as it had originally planned, and had to postpone it to mid to late May Global wars and fuel shocks are putting pregnant women at greater risk of dying in childbirthBy Emily MacleanAs wars disrupt fuel supplies and health systems, more women are being forced to give birth without timely access to skilled care Can talks save South Africa’s NHI from a courtroom war?By Mia Malan and Anna-Maria van NiekerkHealth Minister Aaron Motsoaledi has met the South African Medical Association — one of the organisations taking him to court about the National Health Insurance Act — to talk about “things we have in common”. President Cyril Ramaphosa is planning to meet Business Unity South Africa again after an initial meeting in 2024, during which they discussed alternatives to the NHI How a boy born on World TB Day helped turn the tide on SA’s deadliest TBBy Sean ChristieNorbert Ndjeka was born on World TB Day. Decades later, he would reshape how South Africa treats the deadliest forms of the disease 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
Teen pregnancies are dramatically dropping. But researchers aren’t sure whyBy Tanya PampaloneNew research shows a steep decline in adolescent pregnancy rates across all nine provinces from 2021 to 2025, reversing course from previous years. It’s good news, even if it’s not clear why it’s happening Our anti-HIV jab will be rolled out in six weeks. But funding cuts hollowed out the system needed to deliver itBy Mia MalanThe uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the Trump administration’s funding cuts to the country, a new report has found. Researchers conducted in-depth interviews with doctors, nurses, peer counsellors, transgender and young people, sex workers, gay and bisexual men and government health workers with personal experience of the funding cuts in Cape Town and Johannesburg The spirits, the marabouts and the 11 psychiatrists in Burkina FasoBy Sean ChristieIn Burkina Faso, more than 70 languages are spoken, armed conflict continues to escalate and half the country’s psychiatrists have left. With few mental health services available, families and traditional healers absorb what the system cannot Here’s how to make drug addiction a health issue, not a criminal oneBy Tanya Pampalone, Anna-Maria van Niekerk, Jessica Pitchford and Mia MalanExperts say South Africa’s contradictory approach to drugs — treating addiction as both a disease and a crime — is fuelling a worsening crisis in places like Westbury, where illicit drugs plague the community Our LEN is here; Now for quality checks in IrelandBy Mia MalanSA’s first consignment of the twice-a-year anti-HIV injection, lenacapavir — 37 920 doses — arrived last week at OR Tambo Airport via two shipments from Dublin. The batches reached the country six weeks later than expected. The delay of the shipment meant the health department couldn’t start its roll-out on April 1, as it had originally planned, and had to postpone it to mid to late May Global wars and fuel shocks are putting pregnant women at greater risk of dying in childbirthBy Emily MacleanAs wars disrupt fuel supplies and health systems, more women are being forced to give birth without timely access to skilled care Can talks save South Africa’s NHI from a courtroom war?By Mia Malan and Anna-Maria van NiekerkHealth Minister Aaron Motsoaledi has met the South African Medical Association — one of the organisations taking him to court about the National Health Insurance Act — to talk about “things we have in common”. President Cyril Ramaphosa is planning to meet Business Unity South Africa again after an initial meeting in 2024, during which they discussed alternatives to the NHI How a boy born on World TB Day helped turn the tide on SA’s deadliest TBBy Sean ChristieNorbert Ndjeka was born on World TB Day. Decades later, he would reshape how South Africa treats the deadliest forms of the disease 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
Our anti-HIV jab will be rolled out in six weeks. But funding cuts hollowed out the system needed to deliver itBy Mia MalanThe uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the Trump administration’s funding cuts to the country, a new report has found. Researchers conducted in-depth interviews with doctors, nurses, peer counsellors, transgender and young people, sex workers, gay and bisexual men and government health workers with personal experience of the funding cuts in Cape Town and Johannesburg The spirits, the marabouts and the 11 psychiatrists in Burkina FasoBy Sean ChristieIn Burkina Faso, more than 70 languages are spoken, armed conflict continues to escalate and half the country’s psychiatrists have left. With few mental health services available, families and traditional healers absorb what the system cannot Here’s how to make drug addiction a health issue, not a criminal oneBy Tanya Pampalone, Anna-Maria van Niekerk, Jessica Pitchford and Mia MalanExperts say South Africa’s contradictory approach to drugs — treating addiction as both a disease and a crime — is fuelling a worsening crisis in places like Westbury, where illicit drugs plague the community Our LEN is here; Now for quality checks in IrelandBy Mia MalanSA’s first consignment of the twice-a-year anti-HIV injection, lenacapavir — 37 920 doses — arrived last week at OR Tambo Airport via two shipments from Dublin. The batches reached the country six weeks later than expected. The delay of the shipment meant the health department couldn’t start its roll-out on April 1, as it had originally planned, and had to postpone it to mid to late May Global wars and fuel shocks are putting pregnant women at greater risk of dying in childbirthBy Emily MacleanAs wars disrupt fuel supplies and health systems, more women are being forced to give birth without timely access to skilled care Can talks save South Africa’s NHI from a courtroom war?By Mia Malan and Anna-Maria van NiekerkHealth Minister Aaron Motsoaledi has met the South African Medical Association — one of the organisations taking him to court about the National Health Insurance Act — to talk about “things we have in common”. President Cyril Ramaphosa is planning to meet Business Unity South Africa again after an initial meeting in 2024, during which they discussed alternatives to the NHI How a boy born on World TB Day helped turn the tide on SA’s deadliest TBBy Sean ChristieNorbert Ndjeka was born on World TB Day. Decades later, he would reshape how South Africa treats the deadliest forms of the disease 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
The spirits, the marabouts and the 11 psychiatrists in Burkina FasoBy Sean ChristieIn Burkina Faso, more than 70 languages are spoken, armed conflict continues to escalate and half the country’s psychiatrists have left. With few mental health services available, families and traditional healers absorb what the system cannot Here’s how to make drug addiction a health issue, not a criminal oneBy Tanya Pampalone, Anna-Maria van Niekerk, Jessica Pitchford and Mia MalanExperts say South Africa’s contradictory approach to drugs — treating addiction as both a disease and a crime — is fuelling a worsening crisis in places like Westbury, where illicit drugs plague the community Our LEN is here; Now for quality checks in IrelandBy Mia MalanSA’s first consignment of the twice-a-year anti-HIV injection, lenacapavir — 37 920 doses — arrived last week at OR Tambo Airport via two shipments from Dublin. The batches reached the country six weeks later than expected. The delay of the shipment meant the health department couldn’t start its roll-out on April 1, as it had originally planned, and had to postpone it to mid to late May Global wars and fuel shocks are putting pregnant women at greater risk of dying in childbirthBy Emily MacleanAs wars disrupt fuel supplies and health systems, more women are being forced to give birth without timely access to skilled care Can talks save South Africa’s NHI from a courtroom war?By Mia Malan and Anna-Maria van NiekerkHealth Minister Aaron Motsoaledi has met the South African Medical Association — one of the organisations taking him to court about the National Health Insurance Act — to talk about “things we have in common”. President Cyril Ramaphosa is planning to meet Business Unity South Africa again after an initial meeting in 2024, during which they discussed alternatives to the NHI How a boy born on World TB Day helped turn the tide on SA’s deadliest TBBy Sean ChristieNorbert Ndjeka was born on World TB Day. Decades later, he would reshape how South Africa treats the deadliest forms of the disease 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
Here’s how to make drug addiction a health issue, not a criminal oneBy Tanya Pampalone, Anna-Maria van Niekerk, Jessica Pitchford and Mia MalanExperts say South Africa’s contradictory approach to drugs — treating addiction as both a disease and a crime — is fuelling a worsening crisis in places like Westbury, where illicit drugs plague the community Our LEN is here; Now for quality checks in IrelandBy Mia MalanSA’s first consignment of the twice-a-year anti-HIV injection, lenacapavir — 37 920 doses — arrived last week at OR Tambo Airport via two shipments from Dublin. The batches reached the country six weeks later than expected. The delay of the shipment meant the health department couldn’t start its roll-out on April 1, as it had originally planned, and had to postpone it to mid to late May Global wars and fuel shocks are putting pregnant women at greater risk of dying in childbirthBy Emily MacleanAs wars disrupt fuel supplies and health systems, more women are being forced to give birth without timely access to skilled care Can talks save South Africa’s NHI from a courtroom war?By Mia Malan and Anna-Maria van NiekerkHealth Minister Aaron Motsoaledi has met the South African Medical Association — one of the organisations taking him to court about the National Health Insurance Act — to talk about “things we have in common”. President Cyril Ramaphosa is planning to meet Business Unity South Africa again after an initial meeting in 2024, during which they discussed alternatives to the NHI How a boy born on World TB Day helped turn the tide on SA’s deadliest TBBy Sean ChristieNorbert Ndjeka was born on World TB Day. Decades later, he would reshape how South Africa treats the deadliest forms of the disease 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
Our LEN is here; Now for quality checks in IrelandBy Mia MalanSA’s first consignment of the twice-a-year anti-HIV injection, lenacapavir — 37 920 doses — arrived last week at OR Tambo Airport via two shipments from Dublin. The batches reached the country six weeks later than expected. The delay of the shipment meant the health department couldn’t start its roll-out on April 1, as it had originally planned, and had to postpone it to mid to late May Global wars and fuel shocks are putting pregnant women at greater risk of dying in childbirthBy Emily MacleanAs wars disrupt fuel supplies and health systems, more women are being forced to give birth without timely access to skilled care Can talks save South Africa’s NHI from a courtroom war?By Mia Malan and Anna-Maria van NiekerkHealth Minister Aaron Motsoaledi has met the South African Medical Association — one of the organisations taking him to court about the National Health Insurance Act — to talk about “things we have in common”. President Cyril Ramaphosa is planning to meet Business Unity South Africa again after an initial meeting in 2024, during which they discussed alternatives to the NHI How a boy born on World TB Day helped turn the tide on SA’s deadliest TBBy Sean ChristieNorbert Ndjeka was born on World TB Day. Decades later, he would reshape how South Africa treats the deadliest forms of the disease 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
Global wars and fuel shocks are putting pregnant women at greater risk of dying in childbirthBy Emily MacleanAs wars disrupt fuel supplies and health systems, more women are being forced to give birth without timely access to skilled care Can talks save South Africa’s NHI from a courtroom war?By Mia Malan and Anna-Maria van NiekerkHealth Minister Aaron Motsoaledi has met the South African Medical Association — one of the organisations taking him to court about the National Health Insurance Act — to talk about “things we have in common”. President Cyril Ramaphosa is planning to meet Business Unity South Africa again after an initial meeting in 2024, during which they discussed alternatives to the NHI How a boy born on World TB Day helped turn the tide on SA’s deadliest TBBy Sean ChristieNorbert Ndjeka was born on World TB Day. Decades later, he would reshape how South Africa treats the deadliest forms of the disease 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
Can talks save South Africa’s NHI from a courtroom war?By Mia Malan and Anna-Maria van NiekerkHealth Minister Aaron Motsoaledi has met the South African Medical Association — one of the organisations taking him to court about the National Health Insurance Act — to talk about “things we have in common”. President Cyril Ramaphosa is planning to meet Business Unity South Africa again after an initial meeting in 2024, during which they discussed alternatives to the NHI How a boy born on World TB Day helped turn the tide on SA’s deadliest TBBy Sean ChristieNorbert Ndjeka was born on World TB Day. Decades later, he would reshape how South Africa treats the deadliest forms of the disease 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
How a boy born on World TB Day helped turn the tide on SA’s deadliest TBBy Sean ChristieNorbert Ndjeka was born on World TB Day. Decades later, he would reshape how South Africa treats the deadliest forms of the disease 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enoughBy Linda PretoriusThe HIV prevention shot, lenacapavir, will be rolled out at South African clinics within the next couple of months and from 2027, the health department will also buy generics. But how best to spend the HIV prevention budget so that the country can drive infections down as fast as possible? We take a look at what the modelling data shows Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
Life between cyclones: How Beira’s people carry the mental weight of storms that never really end By Sean ChristieSix years after Cyclone Idai ripped through Beira, the city’s wounds — physical and psychological — are still raw. As a new storm gathered in the Indian Ocean in February, journalist Sean Christie found a city caught in a permanent state of waiting for the next disaster to hit. Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More Latest News Investment and discovery in Tunisia Is Ngcukaitobi being set up against black empowerment? Editorial: IDC decline should be arrested D-Day for Ramaphosa Billy Monama is staging a revival of memory ANC faces local poll backlash Parliament intensifies scrutiny of Sasol Inside the R1.1bn SA Steel Mills deal now under scrutiny Public Protector vs IDC Human Capital Login Register Remember me Forgot Password? Sign in Register Free Account Lost your password? Please enter your username or email address. You will receive a link to create a new password via email. Email Reset Link body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }
Bringing it home: SA is leading the charge to make anti-HIV jab for Africa By Mia MalanSouth Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country. The original version of the once-every-six-months shot, known as lenacapavir, is produced by the US pharmaceutical company, Gilead Sciences. Sanac will submit a shortlist of successful applicants, who met the requirements of the Council’s expression of interest call, to Gilead by July. Load More